Close

Pfizer (PFE) Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. CSX
4. SPY
5. UAL
6. TSLA
7. BPTS
8. ALK
9. EFX
10. ORCL


Go back to Pfizer (PFE) Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2
Pfizer Inc. (NYSE: PFE) Delayed: 25.33 -0.09 (0.35%)
Previous Close $25.42    52 Week High $37.39 
Open $25.35    52 Week Low $28.25 
Day High $25.46    P/E 15.35 
Day Low $25.28    EPS $1.65 
Volume 17,074,085